Cleared Traditional

K926139 - CATHLINK 20 TITANIUM PORT W/ATT. POLYURETHANE CATH

K926139 is an FDA 510(k) clearance for CATHLINK 20 TITANIUM PORT W/ATT. POLYUR..., manufactured by Bard Access Systems, Inc.. The device is a Class 2 General Hospital device with product code LJT cleared through the Traditional 510(k) pathway after a 757-day FDA review.

K926139 · Bard Access Systems, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1995
Decision
757d
Days
Class 2
Risk

K926139 is an FDA 510(k) clearance for the CATHLINK 20 TITANIUM PORT W/ATT. POLYURETHANE CATH. Classified as Port & Catheter, Implanted, Subcutaneous, Intravascular (product code LJT), Class II - Special Controls.

Submitted by Bard Access Systems, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on January 3, 1995 after a review of 757 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5965 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Bard Access Systems, Inc. devices

FDA 510(k) Submission Details - K926139

510(k) Number K926139 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 07, 1992
Decision Date January 03, 1995
Days to Decision 757 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
628d slower than avg
Panel avg: 129d · This submission: 757d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJT Device Classification - Class 2, Special Controls

Product Code LJT Port & Catheter, Implanted, Subcutaneous, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5965
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJT Port & Catheter, Implanted, Subcutaneous, Intravascular

All 235
Devices cleared under the same product code (LJT) and FDA review panel - the closest regulatory comparables to K926139.
1.0MM 1.8MMO.D. POLYURETHANE DETACHED MODEL
K950131 · Therex Corp. · Mar 1995
STRATO MEDICAL LIFEPORT LPS 7515
K942848 · Strato Medical Corp. · Feb 1995
STRATO MEDICAL INFUSE-A-PORT/INFUSE-A-KIT PERIPORT PERIPHERAL ACCESS SYSTEM
K934518 · Strato Medical Corp. · Jan 1995
VITAL-PORT VASC ACCESS SYS W/DUAL LUM INJECTROL CA
K932411 · Med Institute, Inc. · Sep 1994
VITAL-PORT VASCULAR ACCESS SYSTEM
K934520 · Med Institute, Inc. · Sep 1994
THEREX LOW-PROFILE PORT - TITANIUM MODEL
K942412 · Therex Corp. · Aug 1994